List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

AUGTYRO (repotrectinib) capsules

Lung Cancer

AUGTYRO (repotrectinib) capsules, for oral use Initial U.S. Approval: 2023

AUGTYRO is used to treat a certain type of lung cancer (non-small cell lung cancer-NSCLC). Repotrectinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.

Brand Name:	AUGTYRO
Generic Name:	repotrectinib
Strength:	Capsules: 40 mg
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “AUGTYRO (repotrectinib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for AUGTYRO (repotrectinib) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Avelumab Injection

Gastrointestinal, Kidney, Skin

avelumab injection
for intravenous use Initial U.S. Approval: 2017

Bavencio (avelumab) is a medication used for the treatment of metastatic Merkel cell carcinoma (MCC), locally advanced or metastatic urothelial carcinoma, and renal cell carcinoma (RCC).

Facts about avelumab injection

Disease Indications-Urothelial Carcinoma, Kidney Cancer, Skin Cancer
Manufacturer-Merck Serono Europe Limited
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “avelumab injection” based on the information you provide.

Belinostat for Injection

Lymphoma

belinostat for injection,
for intravenous administration Initial U.S. Approval: 2014

Belinostat is is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).

Facts about belinostat for injection

Disease Indications-Lymphoma
Manufacturer-Spectrum Pharmaceuticals, Inc.
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “belinostat for injection” based on the information you provide.

bevacizumab-adcd injection

Colon, Gynaecological, Kidney, Liver, Lung Cancer

bevacizumab-adcd injection
for intravenous use Initial U.S. Approval: 2022

Vegzelma is indicated for the treatment of six types of cancer: metastatic colorectal cancer; recurrent or metastatic non-squamous non-small cell lung cancer (nsNSCLC); recurrent glioblastoma; metastatic renal cell carcinoma; persistent, recurrent, or metastatic cervical cancer; and epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Facts about bevacizumab-adcd injection

Disease Indications-Colorectal Cancer, Gynaecological Cancer, Kidney Cancer, Liver Cancer, Lung Cancer
Manufacturer-Celltrion Healthcare Hungary Kft
Usage-Injection: 100 mg/4 mL (25 mg/mL) or 400 mg/16 mL (25 mg/mL) in a single-dose vial
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “bevacizumab-adcd injection” based on the information you provide.

BIMZELX (bimekizumab-bkzx) injection

Skin

BIMZELX (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023

Bimzelx is a medicine used to treat the following inflammatory diseases: moderate-to-severe plaque psoriasis (red, scaly patches on the skin) in adults who need systemic treatment (treatment with medicines affecting the whole body).

Brand Name:	BIMZELX
Generic Name:	bimekizumab-bkzx
Strength:	Injection: 160 mg/mL in a single-dose prefilled syringe or single-dose prefilled autoinjector.
Manufacturer:	UCB, Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “BIMZELX (bimekizumab-bkzx) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for BIMZELX (bimekizumab-bkzx) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Binimetinib Tablets

Skin

Generic Name: (Binimetinib). It is used to treat melanoma and non-small cell lung cancer (NSCLC).

Mektovi (binimetinib) is indicated in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation1,2.

Facts about binimetinib tablets

Disease Indications-Skin Cancer
Manufacturer-Pierre Fabre Medicament
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Binimetinib Tablets” based on the information you provide.

BIZENGRI (zenocutuzumab-zbco) Injection

Lung Cancer, Gastrointestinal, Pancreatic, Solid Tumors

Brand Name: BIZENGRI. Generic Name: (zenocutuzumab-zbco). It is used to treat non–small cell lung cancer (NSCLC) or pancreatic adenocarcinoma.

BIZENGRI is a prescription medicine used to treat adults with non–small cell lung cancer (NSCLC) or pancreatic adenocarcinoma.

Brand Name:	BIZENGRI
Generic Name:	zenocutuzumab-zbco
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “BIZENGRI (zenocutuzumab-zbco) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Bortezomib for Injection

Multiple Myeloma, Lymphoma

Bortezomib Injection
for subcutaneous use Initial U.S. Approval: 2003

bortezomib is a proteasome inhibitor indicated for:
• treatment of patients with multiple myeloma
• treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.

Facts about Bortezomib for Injection

Approval Date: 2003
Proprietary Name: On Request
Active Ingredient(s): Bortezomib for Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Bortezomib for Injection” based on the information you provide.

BRAFTOVI (encorafenib) capsules

Skin

Brand Name: BRAFTOVI. Generic Name: encorafenib. It is used to treat adults with a type of skin cancer called melanoma.

Encorafenib, sold under the brand name Braftovi, is an anti-cancer medication used for the treatment of certain melanoma cancers.

Brand Name:	BRAFTOVI
Generic Name:	encorafenib
Strength:	• Capsules: 75 mg
Manufacturer:	Pfizer Inc.
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

IPN, New Delhi can facilitate patient to import of “BRAFTOVI (encorafenib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Brentuximab Vedotin for Injection

Lymphoma

brentuximab vedotin for injection,
for intravenous use Initial U.S. approval: 2011

brentuximab vedotin is a prescription medicine used to treat adults with certain lymphomas that are CD30-positive.

Facts about brentuximab vedotin for injection

DISEASE INDICATIONS-Lymphoma
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), NMPA (China)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “brentuximab vedotin for injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

AUGTYRO (repotrectinib) capsules, for oral use Initial U.S. Approval: 2023

avelumab injection for intravenous use Initial U.S. Approval: 2017

Facts about avelumab injection

Access the best support services globally

belinostat for injection, for intravenous administration Initial U.S. Approval: 2014

Facts about belinostat for injection

Access the best support services globally

bevacizumab-adcd injection for intravenous use Initial U.S. Approval: 2022

Facts about bevacizumab-adcd injection

Access the best support services globally

BIMZELX (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023

Generic Name: (Binimetinib). It is used to treat melanoma and non-small cell lung cancer (NSCLC).

Facts about binimetinib tablets

Access the best support services globally

Brand Name: BIZENGRI. Generic Name: (zenocutuzumab-zbco). It is used to treat non–small cell lung cancer (NSCLC) or pancreatic adenocarcinoma.

Bortezomib Injection for subcutaneous use Initial U.S. Approval: 2003

Facts about Bortezomib for Injection

Access the best support services globally

Brand Name: BRAFTOVI. Generic Name: encorafenib. It is used to treat adults with a type of skin cancer called melanoma.

brentuximab vedotin for injection, for intravenous use Initial U.S. approval: 2011

Facts about brentuximab vedotin for injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

avelumab injection
for intravenous use Initial U.S. Approval: 2017

belinostat for injection,
for intravenous administration Initial U.S. Approval: 2014

bevacizumab-adcd injection
for intravenous use Initial U.S. Approval: 2022

Bortezomib Injection
for subcutaneous use Initial U.S. Approval: 2003

brentuximab vedotin for injection,
for intravenous use Initial U.S. approval: 2011